Skip to main content
. 2013 Oct 8;70(1):37–45. doi: 10.1007/s00228-013-1592-7

Fig. 1.

Fig. 1

Mean (95 % CI) plasma concentrations of vercirnon and metabolites GSK2635622 and GSK2656694 following vercirnon 500 mg BID for 6 days (n = 6)